The percentages of the phosphorylated form of AKT, mTOR, and S6K kinases were increased in CML compared to the controls (p < 0.01, p < 0.001, Figure 3b). The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.